{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:39:50Z","timestamp":1791319190729,"version":"4.3.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jacep.2022.12.008","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T14:09:13Z","timestamp":1677074953000},"page":"715-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Management of Ventricular Arrhythmias\u00a0Worldwide"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9812-5519","authenticated-orcid":false,"given":"Hilke","family":"K\u00f6nemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ellermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Zeppenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3735-8503","authenticated-orcid":false,"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"40","key":"10.1016\/j.jacep.2022.12.008_bib1","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.jacep.2022.12.008_bib2","first-page":"822","article-title":"2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society Position Statement on the management of ventricular tachycardia and fibrillation in patients with structural heart disease","volume":"36","author":"Deyell","year":"2020","journal-title":"Can J Cardiol"},{"issue":"14","key":"10.1016\/j.jacep.2022.12.008_bib3","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.jacep.2022.12.008_bib4","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJM198511213132101","article-title":"Echocardiographically documented mitral-valve prolapse. Long-term follow-up of 237 patients","volume":"313","author":"Nishimura","year":"1985","journal-title":"N\u00a0Engl J Med"},{"issue":"23 Pt A","key":"10.1016\/j.jacep.2022.12.008_bib5","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1016\/j.jacc.2018.09.048","article-title":"Arrhythmic mitral valve prolapse: JACC Review Topic of the Week","volume":"72","author":"Miller","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacep.2022.12.008_bib6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.CIR.88.2.782","article-title":"Diagnostic criteria for the long QT syndrome. An update","volume":"88","author":"Schwartz","year":"1993","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacep.2022.12.008_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.hrthm.2015.08.038","article-title":"Risk stratification in Brugada syndrome: clinical characteristics, electrocardiographic parameters, and auxiliary testing","volume":"13","author":"Adler","year":"2016","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1016\/j.jacep.2022.12.008_bib8","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.hrthm.2015.03.015","article-title":"High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia","volume":"12","author":"Hasdemir","year":"2015","journal-title":"Heart Rhythm"},{"issue":"17","key":"10.1016\/j.jacep.2022.12.008_bib9","first-page":"1329","article-title":"Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study","volume":"38","author":"Ortiz","year":"2017","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.jacep.2022.12.008_bib10","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2018.02.056","article-title":"Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator","volume":"71","author":"Chatzidou","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"36","key":"10.1016\/j.jacep.2022.12.008_bib11","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.jacep.2022.12.008_bib12","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol."},{"issue":"1","key":"10.1016\/j.jacep.2022.12.008_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrcardio.2015.110","article-title":"Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms","volume":"13","author":"Frommeyer","year":"2016","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"10.1016\/j.jacep.2022.12.008_bib14","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.amjcard.2008.07.033","volume":"102","author":"Piccini","year":"2008","journal-title":"Am J Cardiol"},{"issue":"22","key":"10.1016\/j.jacep.2022.12.008_bib15","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","article-title":"Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"57","author":"van der Werf","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacep.2022.12.008_bib16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.hrthm.2012.12.035","article-title":"Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia","volume":"10","author":"Watanabe","year":"2013","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.jacep.2022.12.008_bib17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.hrthm.2016.12.010","article-title":"Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"14","author":"Ermakov","year":"2017","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.jacep.2022.12.008_bib18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.hrthm.2018.10.016","article-title":"Ablation compared with drug therapy for recurrent ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: results from a multicenter study","volume":"16","author":"Mahida","year":"2019","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.jacep.2022.12.008_bib19","first-page":"278","article-title":"Safety and efficacy of flecainide associated with beta-blockers in arrhythmogenic right ventricular cardiomyopathy","volume":"24","author":"Rolland","year":"2022","journal-title":"Europace"},{"issue":"24","key":"10.1016\/j.jacep.2022.12.008_bib20","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.jacc.2017.10.025","article-title":"Hydroquinidine prevents life-threatening arrhythmic events in patients with short QT syndrome","volume":"70","author":"Mazzanti","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2022.12.008_bib21","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3389\/fphar.2019.00771","article-title":"Impact of antiarrhythmic drugs on the outcome of short QT syndrome","volume":"10","author":"El-Battrawy","year":"2019","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.jacep.2022.12.008_bib22","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCEP.115.003109","article-title":"Management of Brugada syndrome: thirty-three-year experience using electrophysiologically guided therapy with Class 1A antiarrhythmic drugs","volume":"8","author":"Belhassen","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"22","key":"10.1016\/j.jacep.2022.12.008_bib23","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A\u00a0comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.jacep.2022.12.008_bib24","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.CIR.101.11.1297","article-title":"Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone","volume":"101","author":"Connolly","year":"2000","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jacep.2022.12.008_bib25","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH)","volume":"102","author":"Kuck","year":"2000","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jacep.2022.12.008_bib26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.jacep.2022.12.008_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/europace\/euv411","article-title":"2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"18","author":"Wilkoff","year":"2016","journal-title":"Europace"},{"issue":"9","key":"10.1016\/j.jacep.2022.12.008_bib28","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/europace\/euz065","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"21","author":"Stiles","year":"2019","journal-title":"Europace"},{"issue":"26","key":"10.1016\/j.jacep.2022.12.008_bib29","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.jacep.2022.12.008_bib30","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A\u00a0randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators","volume":"341","author":"Buxton","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.jacep.2022.12.008_bib31","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.jacep.2022.12.008_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.jacep.2022.12.008_bib33","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.jacep.2022.12.008_bib34","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT)","volume":"105","author":"B\u00e4nsch","year":"2002","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.jacep.2022.12.008_bib35","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.jacep.2022.12.008_bib36","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","article-title":"Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with\u00a0nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia\u2014AMIOVIRT","volume":"41","author":"Strickberger","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.jacep.2022.12.008_bib37","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1001\/jama.292.23.2874","article-title":"Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"292","author":"Desai","year":"2004","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jacep.2022.12.008_bib38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamacardio.2017.0630","article-title":"Primary prevention implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy: a meta-analysis","volume":"2","author":"Al-Khatib","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"4","key":"10.1016\/j.jacep.2022.12.008_bib39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.118.039410","article-title":"Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies","volume":"140","author":"Wahbi","year":"2019","journal-title":"Circulation"},{"issue":"30","key":"10.1016\/j.jacep.2022.12.008_bib40","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A\u00a0novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O\u2019Mahony","year":"2014","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jacep.2022.12.008_bib41","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/CIRCEP.113.000102","article-title":"Left cardiac sympathetic denervation in long QT syndrome: analysis of therapeutic nonresponders","volume":"6","author":"Bos","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"10.1016\/j.jacep.2022.12.008_bib42","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/europace\/euab238","article-title":"Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)","volume":"24","author":"Mazzanti","year":"2022","journal-title":"Europace"},{"issue":"25","key":"10.1016\/j.jacep.2022.12.008_bib43","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/CIRCULATIONAHA.115.015731","article-title":"Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation","volume":"131","author":"Ferrari","year":"2015","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.jacep.2022.12.008_bib44","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg Canadian Implantable Defibrillator Study","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.jacep.2022.12.008_bib45","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/eurheartj\/ehu040","article-title":"Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30","volume":"35","author":"Maury","year":"2014","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacep.2022.12.008_bib46","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/01.CIR.103.2.244","article-title":"\u201cStable\u201d ventricular tachycardia is not a benign rhythm: insights from the Antiarrhythmics versus Implantable Defibrillators (AVID) registry","volume":"103","author":"Raitt","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacep.2022.12.008_bib47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.jacep.2022.12.008_bib48","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1056\/NEJMoa065457","article-title":"Prophylactic catheter ablation for the prevention of defibrillator therapy","volume":"357","author":"Reddy","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.jacep.2022.12.008_bib49","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/CIRCULATIONAHA.119.043400","article-title":"Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): a multicenter randomized trial","volume":"141","author":"Willems","year":"2020","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.jacep.2022.12.008_bib50","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jacc.2022.01.050","article-title":"Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia","volume":"79","author":"Arenal","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.jacep.2022.12.008_bib51","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/CIRCULATIONAHA.122.059598","article-title":"Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial","volume":"145","author":"Della Bella","year":"2022","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.jacep.2022.12.008_bib52","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1161\/CIRCULATIONAHA.122.060039","article-title":"First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy concurrent with defibrillator implantation: the PAUSE-SCD randomized trial","volume":"145","author":"Tung","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacep.2022.12.008_bib53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCEP.110.957290","article-title":"Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy","volume":"4","author":"Dukkipati","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"10.1016\/j.jacep.2022.12.008_bib54","first-page":"339","article-title":"Radiofrequency catheter ablation of ventricular tachycardia in patients with hypertrophic cardiomyopathy and apical aneurysm","volume":"4","author":"Igarashi","year":"2018","journal-title":"J\u00a0Am Coll Cardiol EP"},{"issue":"2","key":"10.1016\/j.jacep.2022.12.008_bib55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCEP.113.000805","article-title":"Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study","volume":"7","author":"Ling","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"41","key":"10.1016\/j.jacep.2022.12.008_bib56","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X22010945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X22010945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:31:35Z","timestamp":1762500695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X22010945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2405500X22010945"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2022.12.008","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Ventricular Arrhythmias\u00a0Worldwide","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2022.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}